Christoph Samuel Ziegler

Director

Director at Veraxa Biotech AG - Post de-SPAC, filing insider transactions on 2026-10-20.

Total Purchases

$33K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1 total filings

Active Since

2026-10-20

Last: 2026-10-20

Companies

Veraxa Biotech AG - Post de-SPAC

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-10-20	VRXA	Purchase	30.0K	$1.09	$33K	37.9K	SEC ↗